The companies will continue with their exclusive agreements, including commercialization of their current portfolio
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases
The covid health center will be managed and administered by the district administration of Ballari
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
This is the company’s first partnership arrangement in China
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Subscribe To Our Newsletter & Stay Updated
